The effect of progestins on submaxillary gland epidermal growth factor: demonstration of androgenic, synandrogenic and antiandrogenic actions.

PubWeight™: 0.89‹?›

🔗 View Article (PMID 1140168)

Published in Endocrinology on July 01, 1975

Authors

L P Bullock, P L Barthe, I Mowszowicz, D N Orth, C W Bardin

Articles by these authors

Normal and abnormal regulation of beta-msh in man. J Clin Invest (1969) 2.68

Radioimmunoassay of beta-MSH in human plasma and tissues. J Clin Invest (1967) 2.44

Human plasma epidermal growth factor/beta-urogastrone is associated with blood platelets. J Clin Invest (1983) 2.24

Episodic luteinizing hormone secretion in man. Pulse analysis, clinical interpretation, physiologic mechanisms. J Clin Invest (1973) 2.23

Clinical and laboratory studies of ectopic humoral syndromes. Recent Prog Horm Res (1969) 2.16

Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder. Am J Psychiatry (1999) 1.96

The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation. Recent Prog Horm Res (1996) 1.94

Ornithine decarboxylase in mouse kidney. Purification, characterization, and radioimmunological determination of the enzyme protein. J Biol Chem (1983) 1.88

Epidermal growth factor: effects of androgens and adrenergic agents. Endocrinology (1974) 1.87

Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med (1998) 1.84

Androgen induction of ornithine decarboxylase mRNA in mouse kidney as studied by complementary DNA. Proc Natl Acad Sci U S A (1984) 1.81

Studies on Leydig cell physiology and pathology: secretion and metabolism of testosterone. Recent Prog Horm Res (1966) 1.74

Results of treatment in 108 patients with Cushing's syndrome. N Engl J Med (1971) 1.69

Prevention of cyclical attacks of acute intermittent porphyria with a long-acting agonist of luteinizing hormone-releasing hormone. N Engl J Med (1984) 1.68

Radioimmunoassay of epidermal growth factor. Endocrinology (1972) 1.62

Light synchronization of the circadian rhythm in plasma cortisol (17-OHCS) concentration in man. J Clin Endocrinol Metab (1969) 1.54

Testosterone: a major determinant of extragenital sexual dimorphism. Science (1981) 1.53

erythro-9-[3-(2-Hydroxynonyl)]adenine is an inhibitor of sperm motility that blocks dynein ATPase and protein carboxylmethylase activities. Proc Natl Acad Sci U S A (1981) 1.48

Testosterone and androstenedione blood production rates in normal women and women with idiopathic hirsutism or polycystic ovaries. J Clin Invest (1967) 1.47

Clinical and laboratory findings and results of therapy in 58 patients with adrenocortical tumors admitted to a single medical center (1951 to 1978). Am J Med (1981) 1.46

Spontaneous aortic aneurysms in blotchy mice. Am J Pathol (1975) 1.40

Studies of the pituitary-Leydig cell axis in young men with hypogonadotropic hypogonadism and hyposmia: comparison with normal men, prepuberal boys, and hypopituitary patients. J Clin Invest (1969) 1.38

Detection and purification of inhibin using antisera generated against synthetic peptide fragments. Methods Enzymol (1989) 1.38

The Cushing syndrome: quest for the Holy Grail. Ann Intern Med (1994) 1.38

Effects of shipping on the immune function in mice. Am J Vet Res (1982) 1.32

Mifepristone (RU 486)--a modulator of progestin and glucocorticoid action. N Engl J Med (1993) 1.29

Diurnal rhythm and disappearance half-time of endogenous plasma immunoreactive beta-MSH (LPH) and ACTH in man. J Clin Endocrinol Metab (1978) 1.27

Species distribution of testosterone-binding globulin. Biol Reprod (1973) 1.26

Immunocytochemical localization of human epidermal growth factor/urogastrone in several human tissues. J Histochem Cytochem (1985) 1.22

Androgen metabolism and mechanism of action in male pseudohermaphroditism: a study of testicular feminization. Recent Prog Horm Res (1973) 1.22

Epidermal growth factor (urogastrone) in human fluids: size heterogeneity. J Clin Endocrinol Metab (1979) 1.21

Cushing's disease with periodic hormonogenesis: one explanation for paradoxical response to dexamethasone. J Clin Endocrinol Metab (1973) 1.20

Epidermal growth factor: identification of a new hormone in human urine. Science (1975) 1.20

Dissociation of the disappearance of bioactive and radioimmunoreactive ACTH from plasma in man. J Clin Endocrinol Metab (1971) 1.18

Results of treating childhood Cushing's disease with pituitary irradiation. N Engl J Med (1977) 1.17

Biologic and immunologic characterization and physical separation of ACTH and ACTH fragments in the ectopic ACTH syndrome. J Clin Invest (1973) 1.17

Primary structure of human corticosteroid binding globulin, deduced from hepatic and pulmonary cDNAs, exhibits homology with serine protease inhibitors. Proc Natl Acad Sci U S A (1987) 1.17

Homologous radioimmunoassay for human epidermal growth factor (urogastrone). J Clin Endocrinol Metab (1978) 1.17

Specific demonstration of the human hypophyseal adrenocortico-melanotropic (ACTH-MSH) cell. J Clin Endocrinol Metab (1974) 1.17

Corticotropin, lipotropin, and beta-endorphin production by a human nonpituitary tumor in culture: evidence for a common precursor. Proc Natl Acad Sci U S A (1978) 1.16

ACTH antibodies in patients receiving depot porcine ACTH to hasten recovery from pituitary-adrenal suppression. J Clin Invest (1967) 1.16

Immortalization of human adult normal prostatic epithelial cells by liposomes containing large T-SV40 gene. J Urol (1991) 1.16

Rapid radioimmunoassay for corticotropin in unextracted human plasma. Clin Chem (1984) 1.15

Evaluation of gonadal function in 107 intersex patients by means of serum antimüllerian hormone measurement. J Clin Endocrinol Metab (1999) 1.15

Dynein ATPase is inhibited selectively in vitro by erythro-9-[3-2-(hydroxynonyl)]adenine. Biochem Biophys Res Commun (1982) 1.14

Effect of synthetic ovine corticotropin-releasing factor. Dose response of plasma adrenocorticotropin and cortisol. J Clin Invest (1983) 1.14

Successful treatment of Cushing's syndrome with the glucocorticoid antagonist RU 486. J Clin Endocrinol Metab (1985) 1.14

Ability of trypsin in mimicking germ cell factors that affect Sertoli cell secretory function. J Cell Physiol (1996) 1.13

Physical properties and binding capacity of testosterone-estradiol-binding globulin in human plasma, determined by polyacrylamide gel electrophoresis. J Biol Chem (1971) 1.13

Two ornithine decarboxylase mRNA species in mouse kidney arise from size heterogeneity at their 3' termini. Proc Natl Acad Sci U S A (1986) 1.13

Ornithine decarboxylase mRNA in mouse kidney: a low abundancy gene product regulated by androgens with rapid kinetics. Ann N Y Acad Sci (1984) 1.12

Receptors for androgen-binding proteins: internalization and intracellular signalling. J Steroid Biochem Mol Biol (1995) 1.12

Site of action of clomiphene citrate in men: a study of the pituitary-Leydig cell axis. J Clin Endocrinol Metab (1967) 1.12

ACTH and MSH production by a single cloned mouse pituitary tumor cell line. Endocrinology (1973) 1.11

Androgen production and metabolism in normal and virilized women. Metabolism (1972) 1.11

Cowden disease: gene marker studies and measurements of epidermal growth factor. Am J Hum Genet (1986) 1.10

Effect of glucocorticoids on plasma testosterone in men. Acta Endocrinol (Copenh) (1978) 1.10

Bioavailability of albumin-bound testosterone. J Clin Endocrinol Metab (1985) 1.10

Natural mutagenesis study of the human steroid 5 alpha-reductase 2 isozyme. Biochemistry (1994) 1.08

Inadequate corpus luteal function in women with benign breast diseases. J Clin Endocrinol Metab (1977) 1.07

Expression of pro-opiomelanocortin-like gene in the testis and epididymis. Proc Natl Acad Sci U S A (1984) 1.07

Mechanisms of action of intrauterine devices. Obstet Gynecol Surv (1996) 1.07

Identification of hormonally responsive proteins in primary Sertoli cell culture medium by anion-exchange high performance liquid chromatography. Endocrinology (1986) 1.07

Differences between ectopic MSH and pituitary MSH. J Clin Endocrinol Metab (1971) 1.06

Sperm 1: a POU-domain gene transiently expressed immediately before meiosis I in the male germ cell. Proc Natl Acad Sci U S A (1993) 1.06

ACTH and beta-endorphin-related peptides are present in multiple sites in the reproductive tract of the male rat. Endocrinology (1982) 1.06

The nature of the immunoreactive lipotropins in human plasma and tissue extracts. J Clin Invest (1978) 1.05

Immunoreactive endorphins, lipotropins and corticotropins in a human nonpituitary tumor: evidence for a common precursor. J Clin Endocrinol Metab (1978) 1.04

Psychiatric phenomenology in Cushing's disease. Pharmacopsychiatry (1992) 1.04

Epidermal growth factor (urogastrone) in human tissues. J Clin Endocrinol Metab (1979) 1.04

Rat Sertoli cell clusterin, alpha 2-macroglobulin, and testins: biosynthesis and differential regulation by germ cells. Mol Cell Endocrinol (1992) 1.04

Inhibition of adrenocorticotropic hormone production by glucocorticoids in mouse pituitary tumor cells. Endocrinology (1973) 1.03

Prostatic ductal system in rats: regional variation in localization of an androgen-repressed gene product, sulfated glycoprotein-2. Endocrinology (1991) 1.03

Radioimmunoassay of human epidermal growth factor (urogastrone). J Clin Endocrinol Metab (1977) 1.03

Androgen receptors in testicular feminization. J Clin Endocrinol Metab (1972) 1.03

Late-onset adrenal hyperplasia in hirsutism. N Engl J Med (1985) 1.03

Expression and regulation of proopiomelanocortin-like gene in the ovary and placenta: comparison with the testis. Endocrinology (1986) 1.01

Effects of testosterone and 7 alpha-methyl-19-nortestosterone (MENT) on sexual and aggressive behaviors in two inbred strains of male mice. Horm Behav (1996) 1.01

Plasma concentrations of immunoreactive human epidermal growth factor (urogastrone) in man. J Clin Endocrinol Metab (1980) 1.01

Adrenoleukodystrophy and adrenomyeloneuropathy associated with partial adrenal insufficiency in three generations of a kindred. Am J Med (1979) 0.99

Heterodimers and homodimers of inhibin subunits have different paracrine action in the modulation of luteinizing hormone-stimulated androgen biosynthesis. Proc Natl Acad Sci U S A (1987) 0.99

Inhibition of the action of sex steroids by gonadotropin-releasing hormone (GnRH) agonists: a new biological effect. Life Sci (1981) 0.99

Clinical trial with 3-keto-desogestrel subdermal implants. Contraception (1991) 0.98

Spermatogenesis in vitro: completion of meiosis and early spermiogenesis. Endocrinology (1983) 0.98

Isolated deficiency of adrenocorticotropin (ACTH) and lipotropins (LPHs). J Clin Endocrinol Metab (1978) 0.98

Androgen receptors in mouse kidney: a study of male, female and androgen-insensitive (tfm-y) mice. Endocrinology (1974) 0.97

Cyproterone acetate versus hydrocortisone treatment in late-onset adrenal hyperplasia. J Clin Endocrinol Metab (1990) 0.97

Specific high-affinity binding protein for human corticotropin-releasing hormone in normal human plasma. Biochem Biophys Res Commun (1987) 0.96

Concentrations of epidermal growth factor, nerve growth factor, and submandibular gland renin in male and female mouse tissue and fluids. Endocrinology (1979) 0.96

Germ cell-conditioned medium contains multiple factors that modulate the secretion of testins, clusterin, and transferrin by Sertoli cells. J Androl (1993) 0.96

Rat clusterin isolated from primary Sertoli cell-enriched culture medium is sulfated glycoprotein-2 (SGP-2). Biochem Biophys Res Commun (1988) 0.95

Transforming growth factor beta in the human prostate: its role in stromal-epithelial interactions in non-cancerous cell culture. Prostate (2001) 0.95

Preliminary characterization of the pituitary melanocyte stimulating hormones of several vertebrate species. Endocrinology (1972) 0.95

DNA-dependent RNA polymerases I and II from kidney. Effect of polyamines on the in vitro transcription of DNA and chromatin. Biochemistry (1975) 0.95

[Ac-D-NAL(2)1,4FD-Phe2,D-Trp3,D-Arg6]-LHRH, a potent antagonist of LHRH, produces transient edema and behavioral changes in rats. Contraception (1984) 0.94

Pituitary microadenomas causing Cushing's disease respond to corticotropin-releasing factor. J Clin Endocrinol Metab (1982) 0.94

The metabolic clearance rate and origin of plasma dihydrotestosterone in man and its conversion to the 5-alpha-androstanediols. J Clin Invest (1971) 0.94